<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04194294</url>
  </required_header>
  <id_info>
    <org_study_id>LIDOCAINE-CI</org_study_id>
    <nct_id>NCT04194294</nct_id>
  </id_info>
  <brief_title>Role of LIDOCAINE IN Pediatric Cochlear Implant Surgery</brief_title>
  <official_title>Intravenous Lidocaine Reduces Remifentanil and Propofol Requirements Without Altering the Electrical Stapedial Reflex Threshold in Pediatric Cochlear Implants</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wahba bakhet</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>bahteem specialized hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Ain Shams University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The stapedius reflex protects the ear from the loud noise. The measurement of the
      intraoperative electrically evoked stapedial reflex threshold (ESRT) during pediatric
      cochlear implants (CIs) is used to confirm that the implant is functioning correctly and
      determine the maximum comfortable level . Total intravenous anesthesia (TIVA) with propofol
      and remifentanil is frequently used for pediatric CIs as it does not suppress the ESRT.
      However, high doses of remifentanil exacerbates postoperative pain and increased opioid
      consumption.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Total intravenous anesthesia (TIVA) with propofol and remifentanil is frequently used for
      pediatric CIs as it does not suppress the ESRT. However, high doses of remifentanil
      exacerbates postoperative pain and increased opioid consumption.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 18, 2015</start_date>
  <completion_date type="Actual">June 5, 2019</completion_date>
  <primary_completion_date type="Actual">June 5, 2019</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Remifentanil consumption</measure>
    <time_frame>at the end of the surgey</time_frame>
    <description>microgram per kilogram</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>ESRT responses</measure>
    <time_frame>After insertion of the electrode and after reversal of any residual muscle relaxant (TOF response &gt; 0.9),</time_frame>
    <description>the surgeon assessed ESRT response at the basal, middle, and apical areas of the electrode array by visual monitoring of the stapedius muscle using direct</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">70</enrollment>
  <condition>Anesthesia</condition>
  <arm_group>
    <arm_group_label>Liocaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group Lid</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Na CL 0.9%</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>group C</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine</intervention_name>
    <description>Before induction of anesthesia; children in group LID received an iv bolus dose of LIDOCAINE 1 mg/kg over 5 minutes followed by 1 mg Kg-1 h-1 ivi until the start of skin closure.</description>
    <arm_group_label>Liocaine</arm_group_label>
    <other_name>Xylocaine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Na CL 0.9%</intervention_name>
    <description>Before induction of anesthesia; children in group C equivalent volumes of Na Cl 0.9% over the same period instead of LIDOCAINE.</description>
    <arm_group_label>Na CL 0.9%</arm_group_label>
    <other_name>isotonic saline solution</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        ASA I and II children

        Exclusion Criteria:

        uncontrolled hypertension, diabetes mellitus, liver disease, kidney disease, heart disease,
        allergy to lidocaine
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Months</minimum_age>
    <maximum_age>6 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>December 9, 2019</study_first_submitted>
  <study_first_submitted_qc>December 10, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 11, 2019</study_first_posted>
  <last_update_submitted>April 30, 2020</last_update_submitted>
  <last_update_submitted_qc>April 30, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 1, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Ain Shams University</investigator_affiliation>
    <investigator_full_name>Wahba bakhet</investigator_full_name>
    <investigator_title>Lectrure of anesthesia</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

